1 April 2022
Pierre has over 20 years of industrial experience in Therapeutics Development from Discovery to Market Authorization in oncology and anti-infectives.
In 1996 he obtained a PhD in Molecular Biology and Biochemistry from the ENSAM of Montpelier followed with a Post graduate position at the Polytechnical School of Zurich (ETHZ).
Over the past 10 years he was dedicated to antibiotic development and has successfully conducted clinical studies in several indications such as Diabetic foot Infection, Prosthetic joint Infections, Acute Bacterial Skin and Skin Structure Infection
Prior to working for GARDP Pierre was a Global Project Leader, Associate Director Portfolio Management at Debiopharm International in charge of the anti-infective platform and Alliance Manager of several programs. He successfully secured contracts with CARB-X to expedite the development of new antibiotics targeting specific pathogens and successfully participated in strategic in-licensing activities to increase value of the Company pipeline.